CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
Clin Mol Hepatol. 2017;23(1):51-56.   Published online 2017 March 16    DOI: https://doi.org/10.3350/cmh.2016.0053

Excel Download

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Clinical and Molecular Hepatology. 2017;23(1):51-56   Crossref logo
Link1 Link2 Link3

Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis
Therapeutic Apheresis and Dialysis. 2016;20(5):462-467   Crossref logo
Link1

Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older
Journal of Medical Virology. 2016;89(1):91-98   Crossref logo
Link1 Link2

Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection
Kidney International. 2020;97(3):615   Crossref logo
Link1 Link2

Low Frequency of Drug-Resistant virus did not Affect the Therapeutic Efficacy in Daclatasvir plus Asunaprevir Therapy in Patients with Chronic HCV Genotype-1 Infection
Antiviral Therapy. 2016;21(1):37-44   Crossref logo
Link1 Link2

Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection
Journal of Medical Virology. 2015;88(3):506-511   Crossref logo
Link1 Link2

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis
Hepatology Research. 2016;47(3):E120-E131   Crossref logo
Link1 Link2 Link3

Real-life efficacy and safety of daclatasvir and asunaprevir therapy for genotype 1b chronic hepatitis C patients without NS5A resistance-associated substitution: A nationwide study in South Korea
Journal of Hepatology. 2018;68:S299-S300   Crossref logo
Link1 Link2

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Clinical and Molecular Hepatology. 2016;22(2):259-266   Crossref logo
Link1 Link2 Link3

Daclatasvir/asunaprevir worth its cost for chronic HCV genotype 1b
PharmacoEconomics & Outcomes News. 2018;797(1):13-13   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.